About this trial

This is a prospective trial that attempts to develop evidence on the safety and performance of RA-TKA (Robotic-assisted total knee arthroplasty) with Skywalker and eMP (Evolution Medial Pivot) knee. Moreover to evaluate performance of eMP patients with Skywalker (in comparison to eMP with conventional instrumentations and non-MP TKAs)

Eligibility criteria

Qualifiers

>= 18 Years Male or Female

With noninflammatory degenerative joint disease, inflammatory joint disease, functional deformity

The subject has signed the Ethical Board approved Informed Consent Form specific to this study prior to enrollment

Must be independent, ambulatory, and can comply with all post-operative evaluations and visits.

Disqualifiers

Subjects with poor compliance, unable to complete the trial according to the requirements or for other reasons or considered not to be suitable for inclusion by investigators.

Concurrent participation in any other total hip or knee replacement studies.

Trial design

Treatments tested in this trial

  • Robotic TKA
  • Conventional TKA

Treatment groups

122 Participants
are divided into 2 treatment groups

Locations

1
University Hospital of Larisa41334, LarissaThessaly, Greece

Sponsors and collaborators

Orthopaedic Department of General University Hospital of Laria

Lead sponsor

MicroPort Orthopedics Inc.

Collaborator